Effect of dose and repeat intravenous 24 hr infusions of methotrexate on cerebrospinal fluid availability in children with hematological malignancies
- 1 June 1987
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 23 (6) , 843-847
- https://doi.org/10.1016/0277-5379(87)90289-6
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Comparison of serum and cerebrospinal fluid levels of methotrexate in man during high-dose chemotherapy for aggressive non-Hodgkin's lymphomaCancer Chemotherapy and Pharmacology, 1985
- Clinical Pharmacokinetics of Methotrexate in ChildrenClinical Pharmacokinetics, 1984
- Prolonged Methotrexate Infusions in Children with Acute Leukemia in Relapse and in Remission and with MedulloblastomaOncology, 1984
- The Pharmacology and Clinical Use of MethotrexateNew England Journal of Medicine, 1983
- Comparison of Intermediate-Dose Methotrexate with Cranial Irradiation for the Post-Induction Treatment of Acute Lymphocytic Leukemia in ChildrenNew England Journal of Medicine, 1983
- Clinical Pharmacokinetics of Cerebrospinal FluidClinical Pharmacokinetics, 1982
- Change in Transfer Rate of Methotrexate from Spinal Fluid to Plasma during Intrathecal Therapy in Children and AdultsClinical Pharmacokinetics, 1980
- Childhood acute lymphocytic leukemia. Study VIIICancer, 1978
- Methotrexate: Distribution in Cerebrospinal Fluid after Intravenous, Ventricular and Lumbar InjectionsNew England Journal of Medicine, 1975
- Treatment of leukemia with large doses of methotrexate and folinic acid: clinical-biochemical correlatesJournal of Clinical Investigation, 1969